On the Amendment S.Amdt. 1039: Grassley
Amdt. No. 1039; To clarify the authority of the Office of Surveillance and Epidemiology with respect to postmarket drug safety pursuant to recommendations by the Institute of Medicine.
Result: Rejected (46-47, 7 members not voting, 1/2 threshold)
Details: [
click here]